Sotorasib Versus Docetaxel for Previously Treated Patients With KRASG12C Mutated NSCLC: Data From CodeBreaK 200
1 year ago
44
- Homepage
- Lung Cancer
- Sotorasib Versus Docetaxel for Previously Treated Patients With KRASG12C Mutated NSCLC: Data From CodeBreaK 200
Related
Trending
Popular
Reduce your risk of cancer: get involved and have fun
1 year ago
227
Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.





English (US) ·